1 results match your criteria: "the Epidemiology and Biostatistics of the European Institute of Oncology[Affiliation]"
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy.
BJU Int
December 2014
Department of Radiation Oncology, the Epidemiology and Biostatistics of the European Institute of Oncology, Milan, Italy.
Objective: To report the image-guided hypofractionated radiotherapy (hypo-IGRT) outcome for patients with localised prostate cancer according to the new outcome models Trifecta (cancer control, urinary continence, and sexual potency) and SCP (failure-free survival, continence and potency).
Patients And Methods: Between August 2006 and January 2011, 337 patients with cT1-T2N0M0 prostate cancer (median age 73 years) were eligible for a prospective longitudinal study on hypo-IGRT (70.2 Gy/26 fractions) in our Department.